SCHEMBL15928733

SCHEMBL15928733

Nc1cccc(N2CCCCCC2)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRA2C P18825 1/20 0.66
▸ ALDH1A1 P00352 6/20 0.57
▸ MAPT P10636 5/20 0.57
▸ MEN1 O00255 4/20 0.57
▸ KMT2A Q03164 4/20 0.57
▸ GAA P10253 3/20 0.57
▸ ALOX15 P16050 3/20 0.57
▸ KDM4E B2RXH2 3/20 0.57
▸ HTT P42858 2/20 0.57
▸ L3MBTL1 Q9Y468 2/20 0.57
▸ HSD17B10 Q99714 2/20 0.57
▸ POLB P06746 2/20 0.57
▸ RECQL P46063 2/20 0.57
▸ NPC1 O15118 1/20 0.57
▸ USP2 O75604 1/20 0.57
▸ TP53 P04637 1/20 0.57
▸ THRB P10828 1/20 0.57
▸ RAB9A P51151 1/20 0.57
▸ NPSR1 Q6W5P4 1/20 0.57
▸ S100B P04271 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1397693 1.00 ADRA2C (0.66) ADRA2CALDH1A1MAPTMEN1KMT2A
SCHEMBL30469317 1.00 ADRA2C (0.66) ADRA2CALDH1A1MAPTMEN1KMT2A
SCHEMBL29378385 1.00 ADRA2C (0.66) ADRA2CALDH1A1MAPTMEN1KMT2A
Hydrochloric Acid SCHEMBL9014044 0.98 ADRA2C (0.63) ADRA2CALDH1A1MAPTMEN1KMT2A
Hydrochloric Acid SCHEMBL4631044 0.98 ADRA2C (0.63) ADRA2CALDH1A1MAPTMEN1KMT2A
SCHEMBL533024 0.98 ADRA2C (0.68) ADRA2CALDH1A1MAPTMEN1KMT2A
SCHEMBL15289763 0.93 ADRA2C (0.68) ADRA2CALDH1A1MAPTMEN1KMT2A
SCHEMBL6942579 0.89 ADRA2C (0.80) ADRA2CALDH1A1MAPTMEN1KMT2A
Hydrochloric Acid SCHEMBL7077636 0.86 ADRA2C (0.77) ADRA2CALDH1A1MAPTMEN1KMT2A
SCHEMBL22685038 0.86 ALDH1A1 (0.59) ADRA2CALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12358869-B2 Diarylureas as CB1 allosteric modulators RESEARCH TRIANGLE INSTITUTE 2025-07-15 — — US disclosed
US-20210332007-A1 DIARYLUREAS AS CB1 ALLOSTERIC MODULATORS RESEARCH TRIANGLE INSTITUTE 2021-10-28 — — US disclosed
US-11084781-B2 Diarylureas as CB1 allosteric modulators RESEARCH TRIANGLE INSTITUTE (US) 2021-08-10 — — US disclosed
EP-3621951-A1 DIARYLUREAS AS CB1 ALLOSTERIC MODULATORS Research Triangle Institute (US) 2020-03-18 — — EP disclosed
US-20200062699-A1 DIARYLUREAS AS CB1 ALLOSTERIC MODULATORS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2020-02-27 — — US disclosed
WO-2018209030-A1 DIARYLUREAS AS CB1 ALLOSTERIC MODULATORS RTI INTERNATIONAL (US) 2018-11-15 — — WO disclosed
WO-2014118092-A2 DYE COMPOSITION COMPRISING AT LEAST ONE PARTICULAR LIPOPHILIC META-PHENYLENEDIAMINE COUPLER IN A MEDIUM RICH IN FATTY SUBSTANCES, PROCESSES AND DEVICES L'OREAL (FR) 2014-08-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12358869-B2 Diarylureas as CB1 allosteric modulators CNR1, CNR2, GPR18 ADRA2C 139/4885ALDH1A1 2918/4885MAPT 2523/4885
US-11084781-B2 Diarylureas as CB1 allosteric modulators CNR1, CNR2, GPR18 ADRA2C 139/4885ALDH1A1 2918/4885MAPT 2523/4885
US-20200062699-A1 DIARYLUREAS AS CB1 ALLOSTERIC MODULATORS CNR1, CNR2, GPR18 ADRA2C 139/4885ALDH1A1 2918/4885MAPT 2523/4885
US-20210332007-A1 DIARYLUREAS AS CB1 ALLOSTERIC MODULATORS CNR1, CNR2, GPR18 ADRA2C 139/4885ALDH1A1 2918/4885MAPT 2523/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback